Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104910034A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104910034A details a novel ruthenium-catalyzed synthesis for high-purity alpha-beta-diamino acid derivatives, offering cost reduction in pharmaceutical intermediate manufacturing.